We find that increasing the NAD+/NADH balance or overexpressing the NAD+-dependent mitochondrial deacetylase SIRT3, but not SIRT4 or SIRT5, hinder tumorigenicity in neurofibromin-deficient cells, including highly aggressive MPNST models. Here, SIRT5 is linked to malignant peripheral nerve sheath tumor.